Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy
Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy:
- Trastuzumab
- Tafamidis
- Tranexamic acid
- Tamoxifen
Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: